Atlas Trials

Oxytocin HIV Meth Study

Clinical trial NCT02881177 · COMPLETED

Trial details

NCT number
NCT02881177
Sponsor
University of California, San Francisco
Status
COMPLETED
Phase
Phase 1
Study type
INTERVENTIONAL
Amphetamine Use Disorders
Start date
2017-01-01
Primary completion
2018-07-01
Enrollment
48

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.